A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Clinical trial NCT00909402 · COMPLETED

Trial details

NCT number: NCT00909402
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stomach Neoplasms Esophageal Neoplasms

Start date: 2009-11-01
Primary completion: 2012-11-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.